Form D · Biotechnology

IMAGINE PHARMA LLC

Pittsburgh, PA · CIK 0001863161

Offering snapshot reported May 4, 2023 · SEC filing

Reported sold
$350K
Indefinite offering
Investors reported
6
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Jul 18, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$175K$350KJul 28, 2022: $50,000.00Jul 28, 2022May 4, 2023: $350,000.00May 4, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$50,000 → $350,000
  • Reported investors1 → 6

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 4, 2023Amendment$350,000$300,000vs Jul 28, 20226SEC filing
Jan 9, 2023Initial$300,000No comparison1SEC filing
Jul 28, 2022Initial$50,000No comparison1SEC filing
May 24, 2021Initial$0No comparison0SEC filing

Offering details

Securities
Equity, Debt, Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-454036

Source: Form D, filed May 4, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kristin Nevins Executive
Santiago Pujadas Executive
Ngoc Thai Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1401 Forbes Ave Suite 310
Pittsburgh, PA, 15219